Karen S. Flatten
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 10%
- Immunology
- Hematology top 5%
- Co-authors
- Scott H. KaufmannLarry M. KarnitzAnand G. PatelX. Wei MengGuy G. PoirierPaula A. SchneiderKevin L. PetersonSun Hee Lee
- Topics
- DNA Repair Mechanisms (13 papers)PARP inhibition in cancer therapy (11 papers)Cancer therapeutics and mechanisms (10 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Karen S. Flatten
45 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 1.4k
- Oncology 814
- Cancer Research 226
- Immunology 167
- Hematology 158
Countries citing papers authored by Karen S. Flatten
This map shows the geographic impact of Karen S. Flatten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen S. Flatten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen S. Flatten more than expected).
Fields of papers citing papers by Karen S. Flatten
This network shows the impact of papers produced by Karen S. Flatten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen S. Flatten. The network helps show where Karen S. Flatten may publish in the future.
Co-authorship network of co-authors of Karen S. Flatten
This figure shows the co-authorship network connecting the top 25 collaborators of Karen S. Flatten. A scholar is included among the top collaborators of Karen S. Flatten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen S. Flatten. Karen S. Flatten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 62 | |
| 2 | 10 | |
| 3 | Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance | 1 |
| 4 | 23 | |
| 5 | 49 | |
| 6 | 42 | |
| 7 | 6 | |
| 8 | 158 | |
| 9 | 25 | |
| 10 | 43 | |
| 11 | 165 | |
| 12 | 168 | |
| 13 | 16 | |
| 14 | 78 | |
| 15 | 56 | |
| 16 | 41 | |
| 17 | 97 | |
| 18 | 58 | |
| 19 | 108 | |
| 20 | 84 |
About Karen S. Flatten
Karen S. Flatten is a scholar working on Oncology, Toxicology and Molecular Biology, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (13 papers), PARP inhibition in cancer therapy (11 papers) and Cancer therapeutics and mechanisms (10 papers). The work is most often cited by research in Oncology (814 citations), Molecular Biology (1.4k citations) and Cancer Research (226 citations). Karen S. Flatten has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Scott H. Kaufmann, Larry M. Karnitz, Anand G. Patel, X. Wei Meng, Guy G. Poirier, Paula A. Schneider, Kevin L. Peterson, Sun Hee Lee, Judith E. Karp and Nga T. Dai. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.